Do Adenosine Receptors Offer New Therapeutic Options for Diabetic Nephropathy?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|7|4|450-459

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.7, Iss.4, 2009-10, pp. : 450-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options

By  

Current Diabetes Reviews, Vol. 9, Iss. 6, 2013-11 ,pp. : 491-498

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic kidney disease: new treatment options

By Thomas Merlin C  

Diabetes Management, Vol. 3, Iss. 2, 2013-03 ,pp. : 123-130

Future Medicine

Access to resources Recommend Favorite

Diabetic Retinopathy: Current and New Treatment Options

By  

Current Diabetes Reviews, Vol. 8, Iss. 1, 2012-01 ,pp. : 32-41

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic Papillopathy: Current and New Treatment Options

By  

Current Diabetes Reviews, Vol. 7, Iss. 3, 2011-05 ,pp. : 171-175

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of Oxidative Stress Related Genes and New Antioxidant Therapy in Diabetic Nephropathy

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 4, 2011-10 ,pp. : 253-261

Bentham Science Publishers

Access to resources Recommend Favorite